Skip to content
AwardedPOLGoods

SZP.281.13.2026 – Dostawa produktu leczniczego zawierającego substancję czynną – enfortumab vedotin dla Instytutu „CZMP”

Published
Published 23 March 2026

Overview

SZP.281.13.2026 – Dostawa produktu leczniczego zawierającego substancję czynną – enfortumab vedotin dla Instytutu „CZMP”

Key details

Country
POL
Status
Awarded
Category
Goods
Procedure
Direct
Published
23 March 2026
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
PLN 236,366
Award date
20 March 2026
Contract period
— → 9 March 2028
Winner
  • ASTELLAS PHARMA sp. z o. o.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    23 March 2026

Contracting authority

  • Instytut "Centrum Zdrowia Matki Polki"

    Procuring entity

    Łódź, POL

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: SZP.281.13.2026 – Dostawa produktu leczniczego zawierającego substancję czynną – enfortumab vedotin dla Instytutu „CZMP” — won by ASTELLAS PHARMA sp. z o. o. — Skim